Volume : VIII, Issue : VIII, August - 2019

Multiple Sclerosis: Newer Treatments

Dr. Manmeet Pal Kaur, Dr. Sargun Singh

Abstract :

Multiple sclerosis (MS) is a chronic autoimmune disease of central nervous system that usually affects young adults, causing progressive physical and cognitive disability. Its treatment has been based on parenteral medications known collectively as immunomodulators since the 1990s . This drug class is considered safe and usually prevents 30% of MS relapses. Drugs in this class exert almost the same efficacy but require an inconvenient administration route i.e. parenteral leading to decrease compliance . New medications have recently been launched worldwide. New oral drugs are increasingly being used in MS patients contributing to a better quality of life, since these have better efficacy than the old immunomodulators with easier method of administration. Today, 10 different drugs for MS are marketed worldwide, which requires deep knowledge among neurologists and other healthcare professionals. This review article summarizes all the drugs approved for MS in the US and Europe, emphasizing their mechanism of action and the product safety.

Keywords :

Article: Download PDF   DOI : 10.36106/ijsr  

Cite This Article:

MULTIPLE SCLEROSIS: NEWER TREATMENTS, DR. MANMEET PAL KAUR, DR. SARGUN SINGH INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-8 | Issue-8 | August-2019

Number of Downloads : 79

References :